Inc. magazine revealed that PathogenDx, a leader in next-generation microarray technology for better health and safety, is No. 50 on its fourth annual Inc. 5000 Regionals Southwest list, the most prestigious ranking of the fastest-growing private companies based in Arizona, New Mexico, Oklahoma, and Texas. Born of the annual Inc. 5000 franchise, this regional list represents a unique look at the most successful companies within the Southwest economy’s most dynamic segment–its independent small businesses.
“We are once again honored to be named as one of the fastest growing private companies in the Southwest,” said PathogenDx Co-founder and CEO Milan Patel. “While the pandemic elevated people’s awareness of dangers of pathogens – viruses and antibiotic-resistant superbugs continue to surge. Just in the last few months alone, we’ve seen: an uptick in polio and monkeypox cases; new strains of parvo killing dogs; the USDA declaring Salmonella an adulterant in chicken products; multistate Norovirus outbreak from contaminated oysters; antibiotic-resistant gonorrhea strains emerging; and the ‘tripledemic’ of COVID-19, R.S.V. and the flu wreaking havoc on individuals across the world. These issues are not a mere coincidence – they’re a sign that we need to be paying better attention to global health and safety issues. At PathogenDx, we are working hard to develop our next-generation technologies, which have been instrumental in not only saving lives, but also saving significant time and money as we fight these grave public health concerns across multiple sectors.”
“This year’s Inc. 5000 Regional winners represent one of the most exceptional and exciting lists of America’s off-the-charts growth companies,” said Scott Omelianuk, editor-in-chief of Inc. magazine. “They’re disruptors and job creators, and all delivered an outsized impact on the economy. Remember their names and follow their lead. These are the companies you’ll be hearing about for years to come.
